Glycoprotein B (EBV) 靶点蛋白|抗体药物|临床药物信息 - ACROBiosystems中国

> 【Glycoprotein B (EBV)】

Glycoprotein B (EBV)信息

英文名称：Envelope glycoprotein B, gB
中文名称：
靶点别称：UL55

上市药物数量：0
临床药物数量：2
最高研发阶段：临床二期

Glycoprotein B (EBV)分子别名

gB

Glycoprotein B (EBV)分子背景

Epstein-Bar Virus (EBV), also known as human herpesvirus 4, belongs to gamma herpes virus family and is a very common human virus worldwide. EBV causes infectious mononucleosis (IM) and also associates to some specific types of cancers such as Burkitt’s lymphoma (BL) and gastric carcinoma (GC). Glycoprotein B (gB) plays an important role in viral entry by binding with αvβ6/αvβ8 integrins to trigger the membrane fusion and entry process of epithelial cells, which makes it become an great target for EBV research.

Glycoprotein B (EBV)临床药物信息

英文名称	研发代码	研发阶段	公司	适应症	临床试验

扫一扫关注微信公众号获取ACRO最新资讯

ACROBiosystems百普赛斯生物科技股份有限公司

全国：+86 400-682-2521

北京：010-53681107

上海：021-50850665

海外：+1 800-810-0816

邮箱：（产品订购）order.cn@acrobiosystems.com

邮箱：（技术支持）tech.cn@acrobiosystems.com

邮箱：（廉洁合规）lianjie@acrobiosystems.com

地址：北京经济技术开发区宏达北路8号5号楼4层

在线留言

发送

消息提示

请输入您的联系方式,再点击提交！